Impeto Medical

Impeto Medical is a French medical device company founded in June 2005 and based in Paris. The company specializes in developing and producing non-invasive medical devices aimed at the early detection and monitoring of peripheral neuropathies, particularly small fiber and autonomic neuropathies. Its flagship product, SUDOSCAN, is a patented device that assesses small nerve fiber function by stimulating sweat glands and analyzing their activity. This technology allows for rapid detection and follow-up of neuropathies, which can be early indicators of diabetes and other neurological conditions. Impeto Medical's devices are certified under ISO 13485:2016, ensuring they meet international quality standards. The company has a global market presence, with significant sales in the United States and China, where SUDOSCAN is recognized and reimbursed by healthcare systems. In November 2021, Impeto Medical was acquired by Withings, aiming to further develop and expand the reach of SUDOSCAN technology while continuing to provide sales and support under the Impeto Medical brand.

• Employees 23
• Founded 2005
• Annual Revenue $14054000
• Total Funding $12878379